{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:24:39Z","timestamp":1790209479059,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11926-018-0763-z","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T07:13:10Z","timestamp":1533280390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies"],"prefix":"10.1007","volume":"20","author":[{"given":"Leandro","family":"Ladislau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louiza","family":"Arouche-Delaperche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"issue":"4","key":"763_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Inflammatory Muscle Diseases. N Engl J Med. 2015;373(4):393\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"763_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337\u201345.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"763_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63(3):713\u201321.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"763_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore). 2014;93(3):150\u20137.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"763_CR5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJ Hengstman","year":"2006","unstructured":"Hengstman GJ, et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006;65(12):1635\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"763_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"\u2022 Watanabe Y, et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry. 2016;87(10):1038\u201344. This study provides a thorough clinical description of anti-SRP and anti-HMGCR in IMNM","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"763_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","volume":"15","author":"L Musset","year":"2016","unstructured":"Musset L, et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmun Rev. 2016;15(10):983\u201393.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"763_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","volume":"16","author":"S Suzuki","year":"2017","unstructured":"Suzuki S, et al. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology. Autoimmun Rev. 2017;16(7):693\u2013700.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"763_CR9","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62(9):2757\u201366.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"763_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","volume":"29","author":"O Benveniste","year":"2016","unstructured":"\u2022 Benveniste O, Stenzel W, Allenbach Y. Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol. 2016;29(5):662\u201373. This study provides a thorough description of autoantibodies in IMM","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"763_CR11","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis. 2001;60(2):116\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"763_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"\u2022 Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280(1):8\u201323. This study provides a thorough description of autoantibodies in IMM","journal-title":"J Intern Med"},{"issue":"24","key":"763_CR13","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","volume":"83","author":"WH Reeves","year":"1986","unstructured":"Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci U S A. 1986;83(24):9507\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"763_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0b013e32833f8f72","volume":"22","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L. Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2010;22(6):623\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"763_CR15","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4468","volume":"16","author":"L Drouot","year":"2014","unstructured":"Drouot L, et al. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Arthritis Res Ther. 2014;16(1):R39.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"763_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMra1515161","volume":"374","author":"AL Mammen","year":"2016","unstructured":"Mammen AL. Statin-Associated Autoimmune Myopathy. N Engl J Med. 2016;374(7):664\u20139.","journal-title":"N Engl J Med"},{"issue":"Pt 8","key":"763_CR17","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"Allenbach Y, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016;139(Pt 8):2131\u20135.","journal-title":"Brain"},{"issue":"4","key":"763_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"\u2022 Pinal-Fernandez I, et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2017;76(4):681\u20137. This study provides a thorough clinical description of anti-SRP severity in IMNM","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"763_CR19","first-page":"787","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, et al. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017;56(5):787\u201394.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"763_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acr.22920","volume":"69","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, et al. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle. Arthritis Care Res (Hoboken). 2017;69(2):263\u201370.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"763_CR21","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMc1506163","volume":"373","author":"AL Mammen","year":"2015","unstructured":"Mammen AL, Tiniakou E. Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy. N Engl J Med. 2015;373(17):1680\u20132.","journal-title":"N Engl J Med"},{"issue":"2","key":"763_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00393-015-0029-3","volume":"75","author":"C Bergua","year":"2016","unstructured":"Bergua C, et al. Immune-mediated necrotizing myopathy. Z Rheumatol. 2016;75(2):151\u20136.","journal-title":"Z Rheumatol"},{"key":"763_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","volume":"10","author":"S Suzuki","year":"2015","unstructured":"Suzuki S, et al. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis. 2015;10:61.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"763_CR24","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, et al. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken). 2010;62(9):1328\u201334.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"763_CR25","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","volume":"28","author":"I Pinal-Fernandez","year":"2016","unstructured":"\u2022\u2022 Pinal-Fernandez I, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol. 2016;28(6):619\u201324. This study provides a thorough clinical description of IMNM","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"763_CR26","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1073\/pnas.77.12.7112","volume":"77","author":"P Walter","year":"1980","unstructured":"Walter P, Blobel G. Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum. Proc Natl Acad Sci U S A. 1980;77(12):7112\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"763_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0092-8674(83)90385-9","volume":"34","author":"P Walter","year":"1983","unstructured":"Walter P, Blobel G. Disassembly and reconstitution of signal recognition particle. Cell. 1983;34(2):525\u201333.","journal-title":"Cell"},{"issue":"1","key":"763_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0092-8674(84)90520-8","volume":"38","author":"P Walter","year":"1984","unstructured":"Walter P, Gilmore R, Blobel G. Protein translocation across the endoplasmic reticulum. Cell. 1984;38(1):5\u20138.","journal-title":"Cell"},{"key":"763_CR29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1146\/annurev.biochem.70.1.755","volume":"70","author":"RJ Keenan","year":"2001","unstructured":"Keenan RJ, et al. The signal recognition particle. Annu Rev Biochem. 2001;70:755\u201375.","journal-title":"Annu Rev Biochem"},{"issue":"1-3","key":"763_CR30","first-page":"17","volume":"1694","author":"J Luirink","year":"2004","unstructured":"Luirink J, Sinning I. SRP-mediated protein targeting: structure and function revisited. Biochim Biophys Acta. 2004;1694(1-3):17\u201335.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"763_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-0854.2011.01171.x","volume":"12","author":"I Saraogi","year":"2011","unstructured":"Saraogi I, Shan SO. Molecular mechanism of co-translational protein targeting by the signal recognition particle. Traffic. 2011;12(5):535\u201342.","journal-title":"Traffic"},{"issue":"2","key":"763_CR32","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar1895","volume":"8","author":"K R\u00f6misch","year":"2006","unstructured":"R\u00f6misch K, et al. Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages. Arthritis Res Ther. 2006;8(2):R39.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"763_CR33","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/art.30344","volume":"63","author":"O Benveniste","year":"2011","unstructured":"Benveniste O, et al. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy. Arthritis Rheum. 2011;63(7):1961\u201371.","journal-title":"Arthritis Rheum"},{"issue":"6257","key":"763_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343(6257):425\u201330.","journal-title":"Nature"},{"issue":"5","key":"763_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/emboj\/19.5.819","volume":"19","author":"ES Istvan","year":"2000","unstructured":"Istvan ES, et al. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 2000;19(5):819\u201330.","journal-title":"EMBO J"},{"issue":"5","key":"763_CR36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1083\/jcb.117.5.959","volume":"117","author":"J Roitelman","year":"1992","unstructured":"Roitelman J, et al. Immunological evidence for eight spans in the membrane domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum. J Cell Biol. 1992;117(5):959\u201373.","journal-title":"J Cell Biol"},{"issue":"12","key":"763_CR37","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.autrev.2013.07.001","volume":"12","author":"PD Hamann","year":"2013","unstructured":"Hamann PD, et al. Statin-induced necrotizing myositis - a discrete autoimmune entity within the \"statin-induced myopathy spectrum\". Autoimmun Rev. 2013;12(12):1177\u201381.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"763_CR38","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","volume":"2","author":"A Alshehri","year":"2015","unstructured":"Alshehri A, et al. Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e124.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"763_CR39","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1002\/art.34673","volume":"64","author":"JL Werner","year":"2012","unstructured":"Werner JL, et al. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum. 2012;64(12):4087\u201393.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"763_CR40","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.nmd.2006.03.002","volume":"16","author":"JB Arlet","year":"2006","unstructured":"Arlet JB, et al. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP). Neuromuscul Disord. 2006;16(5):334\u20136.","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"763_CR41","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","volume":"90","author":"Y Allenbach","year":"2018","unstructured":"\u2022\u2022 Allenbach Y, et al. Necrosis in anti-SRP. Neurology. 2018;90(6):e507\u201317. This study provides a thorough description of the anti-SRP and anti-HMGCR pathogenic role","journal-title":"Neurology"},{"issue":"3","key":"763_CR42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","volume":"25","author":"JL Bleecker De","year":"2015","unstructured":"De Bleecker JL, et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25(3):268\u201372.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"763_CR43","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jnnp.73.4.420","volume":"73","author":"T Miller","year":"2002","unstructured":"Miller T, et al. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry. 2002;73(4):420\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"763_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/mus.20693","volume":"35","author":"D Dimitri","year":"2007","unstructured":"Dimitri D, et al. Myopathy associated with anti-signal recognition peptide antibodies: clinical heterogeneity contrasts with stereotyped histopathology. Muscle Nerve. 2007;35(3):389\u201395.","journal-title":"Muscle Nerve"},{"issue":"7","key":"763_CR45","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","volume":"38","author":"W Stenzel","year":"2012","unstructured":"Stenzel W, Goebel HH, Aronica E. Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features. Neuropathol Appl Neurobiol. 2012;38(7):632\u201346.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"763_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"Chung T, et al. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52(2):189\u201395.","journal-title":"Muscle Nerve"},{"issue":"11","key":"763_CR47","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/mt.2012.189","volume":"20","author":"M Bencze","year":"2012","unstructured":"Bencze M, et al. Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther. 2012;20(11):2168\u201379.","journal-title":"Mol Ther"},{"issue":"2","key":"763_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/stem.1288","volume":"31","author":"M Saclier","year":"2013","unstructured":"Saclier M, et al. Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration. Stem Cells. 2013;31(2):384\u201396.","journal-title":"Stem Cells"},{"issue":"1-2","key":"763_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jneuroim.2013.08.008","volume":"264","author":"A Rojana-udomsart","year":"2013","unstructured":"Rojana-udomsart A, et al. Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). J Neuroimmunol. 2013;264(1-2):65\u201370.","journal-title":"J Neuroimmunol"},{"key":"763_CR50","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Arouche-Delaperche, L., et al., Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol, 2017. This study provides a thorough description of the anti-SRP and anti-HMGCR pathogenic role.","DOI":"10.1002\/ana.24902"},{"issue":"6","key":"763_CR51","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/jcb.24077","volume":"113","author":"L Trapani","year":"2012","unstructured":"Trapani L, et al. 3-hydroxy 3-methylglutaryl coenzyme A reductase inhibition impairs muscle regeneration. J Cell Biochem. 2012;113(6):2057\u201363.","journal-title":"J Cell Biochem"},{"issue":"2","key":"763_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.yexmp.2005.06.008","volume":"79","author":"AK McNally","year":"2005","unstructured":"McNally AK, Anderson JM. Multinucleated giant cell formation exhibits features of phagocytosis with participation of the endoplasmic reticulum. Exp Mol Pathol. 2005;79(2):126\u201335.","journal-title":"Exp Mol Pathol"},{"issue":"46","key":"763_CR53","doi-asserted-by":"publisher","first-page":"35751","DOI":"10.1074\/jbc.M007476200","volume":"275","author":"Y Okazaki","year":"2000","unstructured":"Okazaki Y, et al. Cell surface expression of calnexin, a molecular chaperone in the endoplasmic reticulum. J Biol Chem. 2000;275(46):35751\u20138.","journal-title":"J Biol Chem"},{"issue":"8","key":"763_CR54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, et al. Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res (Hoboken). 2012;64(8):1233\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"18","key":"763_CR55","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1212\/WNL.0000000000003160","volume":"87","author":"Y Ohnuki","year":"2016","unstructured":"Ohnuki Y, et al. HLA-DRB1 alleles in immune-mediated necrotizing myopathy. Neurology. 2016;87(18):1954\u20135.","journal-title":"Neurology"},{"issue":"1","key":"763_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI119517","volume":"100","author":"K Yanase","year":"1997","unstructured":"Yanase K, et al. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest. 1997;100(1):25\u201331.","journal-title":"J Clin Invest"},{"issue":"2","key":"763_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaut.2004.11.008","volume":"24","author":"K Yanase","year":"2005","unstructured":"Yanase K, Madaio MP. Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J Autoimmun. 2005;24(2):145\u201351.","journal-title":"J Autoimmun"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0763-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0763-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T22:27:38Z","timestamp":1720477658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0763-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["763"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0763-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"3 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"56"}}